title: The longevity transporter mIndy (Slc13a5) as a target for treating hepatic steatosis and insulin resistance.
authors.affiliation: Section of Metabolic Vascular Medicine, Medical Clinic III, Dresden University School of Medicine, Technische Universität Dresden, Dresden, Germany.|Paul Langerhans Institute Dresden (PLID), German Center for Diabetes Research (DZD), Dresden, Germany.
authors.forename: Diana M
authors.initials: DM
authors.lastname: Willmes
authors.affiliation: Department of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, RI 02912, USA.
authors.forename: Stephen L
authors.initials: SL
authors.lastname: Helfand
authors.affiliation: Section of Metabolic Vascular Medicine, Medical Clinic III, Dresden University School of Medicine, Technische Universität Dresden, Dresden, Germany.|Paul Langerhans Institute Dresden (PLID), German Center for Diabetes Research (DZD), Dresden, Germany.
authors.forename: Andreas L
authors.initials: AL
authors.lastname: Birkenfeld
mesh_terms: D000818:Animals; D005234:Fatty Liver / Q000378:metabolism*; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology*; D008136:Longevity / Q000502:physiology; D027981:Symporters / Q000378:metabolism*
chemical_list: C470492:SLC13A5 protein, human; D027981:Symporters
keywords: INDY; Slc13a5; aging; fatty liver; longevity; type 2 diabetes